Adage Capital Partners Gp, L.L.C. Savara Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $52.3 Billion
- Q2 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Savara Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 6,987,930 shares of SVRA stock, worth $29.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,987,930
Previous 8,287,930
15.69%
Holding current value
$29.6 Million
Previous $41.3 Million
31.77%
% of portfolio
0.05%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding SVRA
# of Institutions
145Shares Held
147MCall Options Held
280KPut Options Held
798K-
Nea Management Company, LLC Timonium, MD24.5MShares$104 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$61.8 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$52.4 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$34.6 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$34 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $484M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.